
Opinion|Videos|August 2, 2024
High-Risk Populations for Severe Pneumococcal Infection
Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
Advertisement
Episodes in this series

- Who are the high-risk
populations for developing invasive pneumococcal disease?- What is the rationale for why certain populations are at risk for severe pneumococcal infections?
- How can we improve inadequate pneumococcal vaccine uptake rates, specifically in historically marginalized groups?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Unexpected Benefits, Unexpected Limits: The Changing Landscape of GLP-1 Research
2
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
3
AbbVie Reaches Agreement With Trump Administration, Joining MFN Initiatives
4
Q&A: Understanding Adherence, Side Effects, and Patient Choice With Oral Semaglutide
5













































































































































































































